Elevated plasma p-tau217 signaled cognitive decline and dementia risk in people with Down syndrome. High p-tau217 and GFAP levels predicted future amyloid buildup. Down syndrome-related Alzheimer's ...
Studies reveal that people with Down syndrome (DS) have over a 90% lifetime risk of developing dementia caused by Alzheimer's disease (AD) as they age. Research from the University of Pittsburgh's ...
Up-and-coming Alzheimer’s blood tests may soon be used for people with Down’s syndrome. In a longitudinal biomarker study of adults with three copies of ...
Hosted on MSN
Blood Tests Predict Dementia in Down Syndrome
Elevated plasma tau phosphorylated at threonine 217 (p-tau217) foreshadowed cognitive decline and progression to dementia in people with Down syndrome, data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results